| |
Seeking to improve medicines currently considered beneficial and
safe for patients, but for which there is an opportunity to improve and extend
the value of the medicine for the patient |
| |
Increasing the sales of existing products through
targeted marketing and promotion |
| |
Continuing to identify and license or acquire
already-approved and lower-risk products and product candidates that
address unmet clinical needs and fit within our strategic focus |
| |
Developing proprietary products and line extensions |
| |
Forming strategic partnerships |
| |
Exploiting our management teams breadth and depth of
commercial and sales experience to build value |
| |
Continuing to produce an attractive financial profile
with high returns on invested capital |